However, a subgroup analysis suggested that the dose of EPO may be important: low-dose EPO (200–300 IU/kg) before anaesthesia was protective against CSA-AKI, whereas high-dose EPO (400–500 IU/kg) was not. The gene discussed is EPO; the disease is acute kidney injury.